Skip to main content

Yong-Jin Yoo

Korea University · 生化学・遺伝学・分子生物学

研究室紹介

Professor Yong-Jin Yoo's research lab focuses on the genetic and molecular mechanisms underlying neurodevelopmental disorders, particularly intellectual disability, autism spectrum disorder, and epileptic encephalopathies. The lab investigates disease-causing mutations in ion channels and neurotransmitter transporters—such as AMPA receptors and SLC6A1—linking specific genetic variants to clinical phenotypes. A key direction involves understanding the pathophysiological basis of Rett syndrome and related conditions through whole-exome sequencing and functional validation. The lab also explores cellular therapies, including microglia replacement strategies, to model and potentially treat neurological diseases.

neurodevelopmental disordersgenetic mutationsion channelsepileptic encephalopathymicroglia replacement

Research Overview

Papers
42
Total Citations
1,330
Papers (5y)
20
Primary Field
生化学・遺伝学・分子生物学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
20total
2021
2022
2023
2024
2025
Citations per year (5y)
345total
20212022202320242025

Selected Papers

15
1
Article|249 citations·2019
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
Vincenzo Salpietro, Christine L. Dixon, Hui Guo, Oscar D. Bello, Jana Vandrovcová, Stéphanie Efthymiou, Reza Maroofian, Gali Heimer, Lydie Bürglen, Stéphanie Valence, Erin Torti, Moritz Hacke
SJR Q1Nature CommunicationsOA

Abstract AMPA receptors (AMPARs) are tetrameric ligand-gated channels made up of combinations of GluA1-4 subunits encoded by GRIA1-4 genes. GluA2 has an especially important role because, following post-transcriptional editing at the Q607 site, it renders heteromultimeric AMPARs Ca 2+ -impermeable, with a linear relationship between current and trans-membrane voltage. Here, we report heterozygous de novo GRIA2 mutations in 28 unrelated patients with intellectual disability (ID) and neurodevelopm

Cellular and Molecular NeuroscienceNeuroscience
2
Article|209 citations·2016
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
Humam Kadara, Murim Choi, J. Zhang, Edwin R. Parra, Jaime Rodriguez‐Canales, Stephen G. Gaffney, Zhenghong Zhao, Carmen Behrens, Junya Fujimoto, Chi-Wan Chow, Yongjin Yoo, Neda Kalhor
SJR Q1Annals of OncologyOA
OncologyMedicine
3
Article|152 citations·2018
Defining the phenotypic spectrum of SLC6A1 mutations
Katrine M. Johannesen, Elena Gardella, Tarja Linnankivi, Carolina Courage, Anne de Saint Martin, Anna‐Elina Lehesjoki, Cyril Mignot, Alexandra Afenjar, Gaëtan Lesca, Marie‐Thérèse Abi‐Warde, Jamel Chelly, Amélie Piton
SJR Q1EpilepsiaOA

OBJECTIVE: Pathogenic SLC6A1 variants were recently described in patients with myoclonic atonic epilepsy (MAE) and intellectual disability (ID). We set out to define the phenotypic spectrum in a larger cohort of SCL6A1-mutated patients. METHODS: We collected 24 SLC6A1 probands and 6 affected family members. Four previously published cases were included for further electroclinical description. In total, we reviewed the electroclinical data of 34 subjects. RESULTS: Cognitive development was impair

RheumatologyMedicine
4
Article|127 citations·2022
Treatment of a genetic brain disease by CNS-wide microglia replacement
Yohei Shibuya, Kevin K. Kumar, Marius Marc-Daniel Mader, Yongjin Yoo, L Angel Ayala, Mu Zhou, Manuel Mohr, Gernot Neumayer, Ishan Kumar, Ryō Yamamoto, Paul Marcoux, Benjamin Liou
SJR Q1Science Translational MedicineOA

Hematopoietic cell transplantation after myeloablative conditioning has been used to treat various genetic metabolic syndromes but is largely ineffective in diseases affecting the brain presumably due to poor and variable myeloid cell incorporation into the central nervous system. Here, we developed and characterized a near-complete and homogeneous replacement of microglia with bone marrow cells in mice without the need for genetic manipulation of donor or host. The high chimerism resulted from

NeurologyNeuroscience
5
Article|98 citations·2023
A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer’s disease
Yongjin Yoo, Gernot Neumayer, Yohei Shibuya, Marius Marc-Daniel Mader, Marius Wernig
SJR Q1Cell stem cellOA
NeurologyNeuroscience
6
Article|85 citations·2017
GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy
Yongjin Yoo, Jane Jung, Yoo‐Na Lee, Youngha Lee, Hyosuk Cho, Eunjung Na, JeaYeok Hong, Eunjin Kim, Jin Sook Lee, Je‐Sang Lee, Chansik Hong, Sang‐Yoon Park
SJR Q1Annals of NeurologyOA

OBJECTIVE: Rett syndrome (RTT) and epileptic encephalopathy (EE) are devastating neurodevelopmental disorders with distinct diagnostic criteria. However, highly heterogeneous and overlapping clinical features often allocate patients into the boundary of the two conditions, complicating accurate diagnosis and appropriate medical interventions. Therefore, we investigated the specific molecular mechanism that allows an understanding of the pathogenesis and relationship of these two conditions. METH

GeneticsBiochemistry, Genetics and Molecular Biology
7
Article|58 citations·2016
GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: Masquerading as Rett syndrome‐like phenotype
Jin Sook Lee, Yongjin Yoo, Byung Chan Lim, Ki Joong Kim, Junghan Song, Murim Choi, Jong‐Hee Chae
SJR Q2American Journal of Medical Genetics Part A

There have been a few reports of GM3 synthase deficiency since the disease of the ganglioside biosynthetic pathway was first reported in 2004. It is characterized by infantile-onset epilepsy with severe intellectual disability, blindness, cutaneous dyspigmentation, and choreoathetosis. Here we report the cases of two Korean female siblings with ST3GAL5 variants, who presented with a Rett-like phenotype. They had delayed speech, hand stereotypies with a loss of purposeful hand movements, and chor

Molecular BiologyBiochemistry, Genetics and Molecular Biology
8
letter|54 citations·2014
JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms
Shogo Shirane, Marito Araki, Soji Morishita, Yoko Edahiro, H. Takei, Yongjin Yoo, Murim Choi, Yoshitaka Sunami, Yasuo Hironaka, Masaaki Noguchi, M Koike, Naohiro Noda
SJR Q1HaematologicaOA

Recurrent somatic mutations in the JAK2, MPL, and CALR genes have been described in patients diagnosed with Philadelphia-negative myeloproliferative neoplasms (MPN), including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). These mutations are generally mutually exclusive, and their profiles in different disease entities are diverse. In PV, JAK2 mutations exist in approximately 95% of patients. However, in ET and PMF patients, JAK2, CALR, and MPL mutation

GeneticsMedicine
9
Article|39 citations·2015
SATB2‐associated syndrome presenting with Rett‐like phenotypes
Jae‐Seong Lee, Yongjin Yoo, Byung Chan Lim, K.J. Kim, Mansoo Choi, Jong‐Hee Chae
SJR Q2Clinical Genetics

The SATB2-associated syndrome (SAS) was proposed recently, after the SATB2 gene was initially discovered to be associated with isolated cleft palate. This syndrome is characterized by intellectual disability with delayed speech development, facial dysmorphism, cleft or high-arched palate, and dentition problems. Here, we describe two novel SATB2 sequence variants in two unrelated patients presenting with Rett-like phenotypes. We performed trio-based whole-exome sequencing in a 17-month-old girl

GeneticsBiochemistry, Genetics and Molecular Biology
10
Article|31 citations·1993
Ubiquitin metabolism in cycling Xenopus egg extracts.
David Mahaffey, Yongjin Yoo, Martin Rechsteiner
SJR Q1Journal of Biological ChemistryOA

Xenopus egg extract is capable of supporting mitosis in vitro, which makes it ideal for biochemical analysis of the cell cycle. Since several studies have implicated the ubiquitin system in cell cycle progression, we have measured ubiquitin conjugation rates, proteolysis of ubiquitin-lysozyme conjugates, and rates of isopeptidase activity in cycling Xenopus egg extracts. Although ubiquitin conjugation in cytostatic factor arrested extract was half that in activated extract, there were no changes

Molecular BiologyBiochemistry, Genetics and Molecular Biology
11
Article|28 citations·2019
Heterozygous variants in MYBPC1 are associated with an expanded neuromuscular phenotype beyond arthrogryposis
Vandana Shashi, Janelle Geist, Youngha Lee, Yongjin Yoo, Unbeom Shin, Kelly Schoch, Jennifer A. Sullivan, Nicholas Stong, Edward C. Smith, Joan Jasien, Peter G. Kranz, Undiagnosed Diseases Network
SJR Q1Human MutationOA

Encoding the slow skeletal muscle isoform of myosin binding protein-C, MYBPC1 is associated with autosomal dominant and recessive forms of arthrogryposis. The authors describe a novel association for MYBPC1 in four patients from three independent families with skeletal muscle weakness, myogenic tremors, and hypotonia with gradual clinical improvement. The patients carried one of two de novo heterozygous variants in MYBPC1, with the p.Leu263Arg variant seen in three individuals and the p.Leu259Pr

Cardiology and Cardiovascular MedicineMedicine
12
Article|27 citations·2016
Wiedemann-Steiner Syndrome With 2 Novel KMT2A Mutations
Jung Min Ko, Jaeso Cho, Yongjin Yoo, Jieun Seo, Murim Choi, Jong‐Hee Chae, Hyeran Lee, Tae‐Joon Cho
SJR Q2Journal of Child Neurology

Wiedemann-Steiner syndrome is a rare genetic disorder characterized by short stature, hairy elbows, facial dysmorphism, and developmental delay. It can also be accompanied by musculoskeletal anomalies such as muscular hypotonia and small hands and feet. Mutations in the KMT2A gene have only recently been identified as the cause of Wiedemann-Steiner syndrome; therefore, only 16 patients from 15 families have been described, and new phenotypic features continue to be added. In this report, we desc

GeneticsBiochemistry, Genetics and Molecular Biology
13
Article|24 citations·2024
Myeloid cell replacement is neuroprotective in chronic experimental autoimmune encephalomyelitis
Marius Marc-Daniel Mader, Alan Napole, Danwei Wu, Micaiah Atkins, Alexa Scavetti, Yohei Shibuya, Aulden Foltz, Oliver Hãhn, Yongjin Yoo, Ron Danziger, Christina Tan, Tony Wyss‐Coray
SJR Q1Nature Neuroscience
NeurologyNeuroscience
14
Article|22 citations·2023
Integrative analyses highlight functional regulatory variants associated with neuropsychiatric diseases
Margaret Guo, David L. Reynolds, Cheen Euong Ang, Yingfei Liu, Yang Zhao, Laura K. Donohue, Zurab Siprashvili, Yang Xue, Yongjin Yoo, Smarajit Mondal, Audrey W. Hong, Jessica Kain
SJR Q1Nature GeneticsOA
GeneticsBiochemistry, Genetics and Molecular Biology
15
Article|22 citations·2015
Rare cases of congenital arthrogryposis multiplex caused by novel recurrent CHRNG mutations
Jieun Seo, In-Ho Choi, Je‐Sang Lee, Yongjin Yoo, Nayoung K. D. Kim, Murim Choi, Jung Min Ko, Yong Beom Shin
SJR Q2Journal of Human Genetics
GeneticsMedicine

Research Areas

GeneticsNeurologyMolecular BiologyCancer ResearchCellular and Molecular NeuroscienceEpidemiology

Yong-Jin Yooの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。